Therapix Biosciences Share Price - TRPX

0.421
-0.009 (-2.09%)
Upgrade to Real-Time
Afterhours (Closed)
0.43
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Therapix Biosciences Ltd TRPX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0207 5.06% 0.43 0.40 0.43 0.425 0.4093 00:00:02
Bid Price Ask Price Spread Spread % News
0.42 0.49 0.07 14.29% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,339 821,319  0.4168683  342,382 3,222,127 0.25 - 4.69
Last Trade Time Type Quantity Stock Price Currency
19:56:38 formt 916  0.421 USD

Therapix Biosciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 2.46M 5.72M 5.72M  -  - -2.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.00% - -

more financials information »

News Therapix Biosciences

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

TRPX Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the Company's operation); and Pain clinic services, including lab services. Its product candidate covers THX-110, THX-150, THX-130 and THX-160.


Your Recent History
NASDAQ
TRPX
Therapix B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.